CencoravsMerck & Company

COR and MRK stock compared: price, dividend, valuation and results, from SEC filings.

COR

Cencora, Inc.

$359.03

Value $69.6B

+2.76%
COR's page

MRK

Merck & Company, Inc.

$147.76

Value $365B

+0.55%
MRK's page

Cencora (COR) has a market value of $69.6B and Merck & Company (MRK) $365B. Over the last year, with dividends, COR moved -0.3% and MRK +66.3%. The P/E is 26.5 for COR and 148.9 for MRK. Dividend yield: COR 0.69%, MRK 2.30%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    COR$69.6B

    MRK$365B

    MRK is 5.2 times COR

  • Revenue, 12 months

    COR$333B

    MRK$67.4B

    COR is 4.9 times MRK

  • Net income, 12 months

    COR$2.6B

    MRK$2.5B

    COR is 1.1 times MRK

  • Operating margin

    COR0.9%

    MRK–

  • ROIC

    COR18.6%

    MRK3.9%

    14.7 points apart

  • P/E

    COR26.5

    MRK148.9

    MRK is 5.6 times COR

  • Dividend yield

    COR0.7%

    MRK2.3%

    1.6 points apart

  • 5-year return

    COR+203.8%

    MRK+104.9%

    98.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

COR+203.8%

MRK+104.9%

10020030020222023202420252026
Returns by period
PeriodCORWith dividendsMRKWith dividends
1 year since November 12, 2025-0.3%Price -1.2%+66.3%Price +61.6%
3 years since November 13, 2023+85.0%+22.8% a yearPrice +80.5%+58.0%+16.5% a yearPrice +44.2%
5 years since November 12, 2021+203.8%+24.9% a yearPrice +186.4%+104.9%+15.4% a yearPrice +75.9%
10 years since November 15, 2016+503.5%+19.7% a yearPrice +351.4%+230.1%+12.7% a yearPrice +143.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CORCencoraMRKMerck & Company

Valuation

CORMRK
Valuation
Price$359.03$147.76
Market value$69.6B$365B
Enterprise value (EV)$78.6B$409B
P/E26.5148.9
P/E, 5-year median21.114.8
P/B22.88.1
EV/EBIT25.886.0
Free cash flow yield5.8%4.0%

Results and growth

CORMRK
Results and growth
Revenue, 12 months$333B$67.4B
Net income, 12 months$2.6B$2.5B
Free cash flow, 12 months$4.1B$14.7B
Earnings per share, 12 months$13.47$0.98
Revenue growth, year on year9.3%1.3%
Revenue growth a year, past+11.1%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

CORMRK
Margins and returns on capital
Gross margin4.0%71.8%
Operating margin0.9%–
Net margin0.8%3.6%
ROIC18.6%3.9%
ROE110.8%5.2%

Balance sheet

CORMRK
Balance sheet
Cash$2.8B$9.7B
Total debt$11.7B$53.8B
Net debt / EBITDA2.25.7
Interest cover–2.4×

Dividends and buybacks

CORMRK
Dividends and buybacks
Dividend yield0.7%2.3%
Dividend per share, 12 months$2.46$3.40
Dividend growth a year, past+5.8%over 5 years+5.8%over 5 years
Buyback yield0.6%1.4%
Shareholder yield1.3%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: COR or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Cencora or Merck & Company?

By market value, Merck & Company ($365B) is about 5.2 times Cencora ($69.6B), at today's prices.

How did COR and MRK stock do over the last 10 years?

Since November 15, 2016, COR's price moved +351.4% and MRK's +143.3%. With dividends: COR +503.5% (+19.7% a year), MRK +230.1% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, COR or MRK?

The dividend yield at today's price is 0.69% for Cencora and 2.30% for Merck & Company. Over the last twelve months they paid $2.46 and $3.40 per share.

What is the P/E of COR and MRK?

At today's price, the P/E is 26.5 for COR and 148.9 for MRK. The median of the last five years was 21.1 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Cencora or Merck & Company?

Over the last twelve months, the net margin was 0.8% for Cencora and 3.6% for Merck & Company, and the operating margin 0.9% and –. Revenue was $333B and $67.4B.

Which is the better investment, Cencora or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.